Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
75.34
+0.26 (+0.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about DexCom, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
P/E Ratio Insights for DexCom
Today 11:00 EDT
Via
Benzinga
If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today
Today 8:21 EDT
The company's innovative devices have helped it generate decent performances.
Via
The Motley Fool
These S&P500 stocks are gapping in today's session
August 28, 2025
Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
Via
Chartmill
These S&P500 stocks are gapping in today's session
August 27, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.
Via
Chartmill
1 Profitable Stock with Impressive Fundamentals and 2 We Find Risky
August 27, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via
StockStory
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
July 31, 2025
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
Via
Benzinga
Topics
Economy
Earnings Scheduled For July 30, 2025
July 30, 2025
Via
Benzinga
2 of Wall Street’s Favorite Stocks Worth Investigating and 1 We Avoid
August 26, 2025
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...
Via
StockStory
Top S&P500 movers in Monday's session
August 25, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via
Chartmill
Nvidia Rises, Wall Street Pauses As Oil Prices Jump To $65: What's Moving Markets Monday?
August 25, 2025
Nvidia Corp. (NASDAQ:NVDA) is up 2% in midday trading Monday, moving within striking distance of its all-time high—now less than 2 percentage points away—as investors remain upbeat ahead of the...
Via
Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
August 25, 2025
Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session.
Via
Chartmill
These S&P500 stocks are gapping in today's session
August 25, 2025
Stay updated with the S&P500 gap up and gap down stocks on Monday. Get a glimpse of the market's movement during today's session.
Via
Chartmill
DexCom Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
August 21, 2025
Via
Benzinga
DexCom Inc (NASDAQ:DXCM) Screened as a Top Growth Stock with Bullish Breakout Potential
August 21, 2025
DexCom (DXCM) shows strong growth fundamentals and a bullish technical breakout pattern, making it a top growth stock candidate.
Via
Chartmill
2 Stocks to Buy on the Dip and Hold for 10 Years
August 16, 2025
There should be plenty of long-term upside for these stocks for investors willing to ride out the storm.
Via
The Motley Fool
Topics
Economy
Government
3 Reasons We’re Fans of DexCom (DXCM)
August 14, 2025
Over the last six months, DexCom’s shares have sunk to $80.25, producing a disappointing 9.9% loss - a stark contrast to the S&P 500’s 5.8% gain. This may have investors wondering how to approach the...
Via
StockStory
Topics
Stocks
DXCM Q2 CY2025 Deep Dive: Volume Growth, Leadership Changes, and New Product Launches Shape Outlook
August 13, 2025
Medical device company DexCom (NASDAQ:DXCM) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The company expects the full year’s...
Via
StockStory
DEXCOM INC (NASDAQ:DXCM): A Top Affordable Growth Pick with Strong Fundamentals and Fair Valuation
August 05, 2025
DexCom (DXCM) offers strong growth, fair valuation, and solid profitability, making it a top pick for investors seeking affordable growth in the medical device sector.
Via
Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
August 04, 2025
Get insights into the S&P500 index performance on Monday. Explore the top gainers and losers within the S&P500 index in today's session.
Via
Chartmill
Stay informed with the top movers within the S&P500 index on Monday.
August 04, 2025
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
Gapping S&P500 stocks in Monday's session
August 04, 2025
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.
Via
Chartmill
DexCom (DXCM) Q2 Revenue Jumps 15%
August 01, 2025
Via
The Motley Fool
Topics
Economy
Forecasting The Future: 11 Analyst Projections For DexCom
July 31, 2025
Via
Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
July 31, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Gapping S&P500 stocks in Thursday's session
July 31, 2025
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.
Via
Chartmill
DexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates
July 30, 2025
Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The company expects the full year’s revenue to be...
Via
StockStory
Topics
Earnings
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.
July 30, 2025
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.
Via
Chartmill
Dexcom Earnings Beat. Diabetes Device Maker Names New CEO.
July 30, 2025
Dexcom stock fell late Wednesday after it reported Q2 earnings that topped expectations and named a new chief executive officer.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Earnings
Initial Public Offering
Earnings To Watch: DexCom (DXCM) Reports Q2 Results Tomorrow
July 28, 2025
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Wednesday after market hours. Here’s what to look for.
Via
StockStory
Topics
Artificial Intelligence
1 Volatile Stock Worth Your Attention and 2 We Find Risky
July 25, 2025
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.